Financials

Discussions Technicals Forecast Seasonals

023910 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to DAIHAN PHARMACEUTICAL operating, investing, and financing activities

023910 free cash flow for Q2 24 is 1.96 B KRW. For 2023, 023910 free cash flow was 17.58 B KRW and operating cash flow was 38.86 B KRW.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—